Latest Articles
‘I would die if my daughter had to go through what I’ve been through’ - echo live
‘I would die if my daughter had to go through what I’ve been through’ echo live
Published: March 25, 2026, 6:44 a.m.
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health - BioSpectrum Asia
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health BioSpectrum Asia
Published: March 25, 2026, 6:37 a.m.
The Invisible Toll: Navigating a Conference with Endometriosis - the-scientist.com
The Invisible Toll: Navigating a Conference with Endometriosis the-scientist.com
Published: March 25, 2026, 4 a.m.
Daisy Edgar-Jones reveals she has a chronic disease - MSN
Daisy Edgar-Jones reveals she has a chronic disease MSN
Published: March 25, 2026, 3:27 a.m.
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program - MSN
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program MSN
Published: March 25, 2026, 3:27 a.m.
It's now taking over nine years to get an endometriosis diagnosis in the UK - MSN
It's now taking over nine years to get an endometriosis diagnosis in the UK MSN
Published: March 25, 2026, 2:19 a.m.
Endometriosis Awareness Month: How it affects fertility and what you should know - News12 | Connecticut
Endometriosis Awareness Month: How it affects fertility and what you should know News12 | Connecticut
Published: March 25, 2026, 1:38 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - digitalmore.co
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis digitalmore.co
Published: March 25, 2026, 12:42 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - The Manila Times
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis The Manila Times
Published: March 25, 2026, 12:24 a.m.
Absci Corp’s 2025 Q4 Call: FDA Delays, Oncology Partnership Shifts, and ABS-201 Timeline Contradictions - Bitget
Absci Corp’s 2025 Q4 Call: FDA Delays, Oncology Partnership Shifts, and ABS-201 Timeline Contradictions Bitget
Published: March 25, 2026, 12:10 a.m.
Link copied to clipboard!